The Food and Drug Administration intends to award a Purchase Order on a sole source basis to Yuming Li, Boyds, MD. The Food and Drug Administration’s Office of Clinical Pharmacology and Biopharmaceutics (OCPB) has been involved in establishing a system for the enhancement of the incorporation of CDISC into pharmacometrics and clinical pharmacology review during 2004 and 2005. The scope includes the creation and facilitation of the application of a software system for CDISC/PKS analysis and reporting, and analyses and evaluation of nonmem data. The contractor is trained in pharmacy and clinical pharmacology practice and software programming and has experience in pharmacometrics programming for the Food and Drug Administration. Yuming Li has been performing a wide range of system development and support activities for the past two years under a predecessor task. He has a set of unique qualifications and capabilities for this task. No REQUEST FOR QUOTE (RFQ) IS AVAILABLE. Not withstanding, any firm who believes it is capable of meeting FDA’s requirement as stated herein may submit a capability statement, which if received within the 7 calendar days of the date of the announcement will be considered. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. All responses or questions regarding this posting must be in writing and can be sent via email to [email protected]. No phone calls will be accepted.

Bid Protests Not Available